82 Days
المصدر:
المشهد
المصدر: المشهد
82 Daysالمشهد
المصدر: المشهد
82 Daysجاهز للتشغيل
جاهز للتشغيل
A recent study has shown that the human papillomavirus (HPV) vaccine reduces cervical cancer deaths by 63% in England since its introduction into the vaccination program in 2008. The results indicate that there were no recorded deaths among women aged 20 to 24 from 2020 to 2024, with a significant reduction in the risk of death among the 30 to 34 age group. It is estimated that the program has helped prevent the deaths of around 200 young women from cancer, though there are warnings of declining vaccination rates following the COVID-19 pandemic.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading